**Core Concept:** Hydroxyurea is an anticancer drug that functions as an inhibitor of ribonucleotide reductase, a key enzyme involved in DNA synthesis and repair. Inhibition of this enzyme leads to decreased DNA synthesis, ultimately causing cell death in rapidly dividing cancer cells.

**Why the Correct Answer is Right:** Hydroxyurea works by inhibiting the enzyme ribonucleotide reductase, which is essential for DNA synthesis and repair. By blocking the activity of this enzyme, hydroxyurea impairs the production of deoxyribonucleotides, essential components for DNA replication and repair. This results in decreased DNA synthesis, leading to cell cycle arrest and eventually cell death in rapidly dividing cancer cells.

**Why Each Wrong Option is Incorrect:**

A. Hydroxyurea does not target the enzyme thymidylate synthase, which is involved in DNA synthesis but is not the primary target for this medication.

B. Hydroxyurea does not inhibit the enzyme topoisomerase II, which plays a role in DNA replication but is not the primary target for this medication.

C. Hydroxyurea does not directly target the enzyme DNA polymerase, which is involved in DNA synthesis but is not the primary target for this medication.

D. Hydroxyurea does not inhibit the enzyme tyrosine kinase, which plays a role in cell signaling but is not the primary target for this medication.

**Clinical Pearl:** Understanding the mechanism of action of hydroxyurea is crucial for understanding its efficacy and potential side effects in cancer treatment. This knowledge can help medical professionals tailor treatment plans for patients and anticipate potential complications.

**Correct Answer:** Hydroxyurea primarily targets the enzyme ribonucleotide reductase, making it a specific inhibitor of DNA synthesis and repair, thus inhibiting cancer cell growth and division.